Drug Shortage Report for SODIUM CHLORIDE INJECTION, USP

Last updated on 2017-10-28 History
Report ID 14445
Drug Identification Number 02139510
Brand name SODIUM CHLORIDE INJECTION, USP
Common or Proper name Sodium Chloride Injection
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) SODIUM CHLORIDE
Strength(s) 234MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 200mL
ATC code B05XA
ATC description I.V. SOLUTION ADDITIVES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2017-07-03
Actual start date
Estimated end date 2017-11-01
Actual end date 2017-10-27
Shortage status Resolved
Updated date 2017-10-28
Company comments We have resolved our supply interruption and replenishment inventories at all distribution centers, effective today.
Health Canada comments
Tier 3 Status No
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2017-10-28 English Compare
v11 2017-10-27 French Compare
v10 2017-10-27 English Compare
v9 2017-10-27 English Compare
v8 2017-10-27 English Compare
v7 2017-09-29 French Compare
v6 2017-09-29 English Compare
v5 2017-08-28 French Compare
v4 2017-08-28 English Compare
v3 2017-07-04 English Compare
v2 2017-06-30 French Compare
v1 2017-06-30 English Compare

Showing 1 to 12 of 12